Barclays
AEHR icon

Barclays’s Aehr Test Systems AEHR Stock Holding History

Barclays’s Portfolio AEHR Stock Details AEHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.73M Buy
101,249
+49,035
+94% +$4.48M ﹤0.01% 1493
2026
Q1 		$1.94M Buy
52,214
+7,834
+18% +$251K ﹤0.01% 2372
2025
Q4 		$896K Buy
44,380
+4,160
+10% +$101K ﹤0.01% 3508
2025
Q3 		$1.21M Sell
40,220
-9,123
-18% -$198K ﹤0.01% 3251
2025
Q2 		$638K Buy
49,343
+18,536
+60% +$176K ﹤0.01% 3617
2025
Q1 		$225K Sell
30,807
-14,098
-31% -$156K ﹤0.01% 3981
2024
Q4 		$747K Sell
44,905
-95,620
-68% -$1.27M ﹤0.01% 3573
2024
Q3 		$1.81M Buy
140,525
+30,119
+27% +$435K ﹤0.01% 2937
2024
Q2 		$1.23M Sell
110,406
-15,454
-12% -$180K ﹤0.01% 2474
2024
Q1 		$1.56M Buy
125,860
+78,866
+168% +$1.31M ﹤0.01% 2772
2023
Q4 		$1.25M Buy
46,994
+37,119
+376% +$1.08M ﹤0.01% 3276
2023
Q3 		$451K Sell
9,875
-1,088
-10% -$50.4K ﹤0.01% 2862
2023
Q2 		$452K Sell
10,963
-12,732
-54% -$418K ﹤0.01% 2817
2023
Q1 		$735K Sell
23,695
-97,906
-81% -$3.15M ﹤0.01% 2972
2022
Q4 		$2.44M Buy
121,601
+120,377
+9,835% +$2.58M ﹤0.01% 2119
2022
Q3 		$17K Buy
+1,224
New +$16.5K ﹤0.01% 4109
2022
Q2 		– Sell
-439
Closed -$4K – 4991
2022
Q1 		$4K Buy
+439
New +$5.61K ﹤0.01% 4714
2021
Q4 		– Sell
-26,717
Closed -$365K – 4096
2021
Q3 		$365K Buy
+26,717
New +$192K ﹤0.01% 3337

Other funds holding AEHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Barclays's AEHR Position: Q2 2026 in Review

Barclays increased its Aehr Test Systems (AEHR) stake by 94% in Q2 2026, buying an estimated $4.48M and bringing the position to 101,249 shares worth $9.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1493.

Barclays first reported a position in AEHR in Q3 2021 and has held it in 18 quarters since. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

  • Barclays held 101,249 shares of Aehr Test Systems worth $9.73M as of Q2 2026.
  • Barclays bought 49,035 Aehr Test Systems shares in Q2 2026, an estimated $4.48M.
  • Aehr Test Systems made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1493 holding.
  • Barclays first reported a position in Aehr Test Systems in Q3 2021 and has held it in 18 quarters since.
  • 262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.